Ifp Advisors, Inc Hepion Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.57 - $1.22 $0 - $1	1 New	1 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.57 - $1.22 $0 - $1	-1 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.93 - $1.29 $0 - $1	1 New	1 $0
Q3 2021 Oct 06, 2021	SELL	$1.39 - $2.1 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.56 - $2.26 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$1.77 - $2.98 $8,850 - $14,900	-5,000 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.58 - $3.64 $7,900 - $18,200	5,000 New	5,000 $11,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.